Mixed connective tissue disease historical perspective: Difference between revisions
No edit summary |
|||
Line 18: | Line 18: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: | [[Category:Medicine]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Rheumatology]] |
Revision as of 13:37, 20 April 2018
Mixed connective tissue disease Microchapters |
Differentiating Mixed connective tissue disease from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Mixed connective tissue disease historical perspective On the Web |
American Roentgen Ray Society Images of Mixed connective tissue disease historical perspective |
FDA on Mixed connective tissue disease historical perspective |
Mixed connective tissue disease historical perspective in the news |
Blogs onMixed connective tissue disease historical perspective |
Directions to Hospitals Treating Mixed connective tissue disease |
Risk calculators and risk factors for Mixed connective tissue disease historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
Overview
- MCTD was first defined by Gordon C.Sharp et al., in 1972. It has been the first rheumatic disease syndrome defined by a serologic test. In 1976, Alarcon-Segovia proposed criteria for classifying MCTD among all types of connective tissue diseases. It demonstrates the close association between MCTD and Sjogren's syndrome.
Historical Perspective
- MCTD was first defined by Gordon C.Sharp et al., in 1972.
- MCTD has been the first rheumatic disease syndrome defined by a serologic test (positive U1RNP).[1][2]
- In 1976, Alarcon-Segovia proposed criteria for classifying mixed connective tissue disease among all types of connective tissue diseases. It demonstrates the close association between MCTD and Sjogren's syndrome.
- In 1987, three sets of criteria for MCTD were proposed by Sharp, Alarcon-Segovia and The Research Committee of Japanese Ministry of Health and Welfare for MCTD (JMHW).[3]
References
- ↑ Vij M, Agrawal V, Jain M (July 2014). "Scleroderma renal crisis in a case of mixed connective tissue disease". Saudi J Kidney Dis Transpl. 25 (4): 844–8. PMID 24969199.
- ↑ Hoffman RW, Maldonado ME (July 2008). "Immune pathogenesis of Mixed Connective Tissue Disease: a short analytical review". Clin. Immunol. 128 (1): 8–17. doi:10.1016/j.clim.2008.03.461. PMID 18439877.
- ↑ Alarcón-Segovia D (October 1984). "Symptomatic Sjögren's syndrome in mixed connective tissue disease". J. Rheumatol. 11 (5): 582–3. PMID 6512789.